How Foster was paid
$368,521 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Total |
|---|---|---|---|
| Steven M. FosterChief Executive Officer | $363,784 | $4,737 | $368,521 |
| Kevin WilliamsonChief Financial Officer | $102,127 | $21,815 | $123,942 |
| Steven Van Dickformer Chief Financial Officer | $318,128 | $3,842 | $321,970 |
| Richard GinnChief Technology Officer | $282,716 | $2,617 | $285,333 |
What changed and why
- $369K$368,521 was CEO total compensation in 2024, versus $487,600 in 2023.
- $4,737$4,737 in 2024 equity awards reflected RSUs received through the employee option-exchange offer.
- $102K$102,127 was Kevin Williamson’s salary after becoming CFO on September 3, 2024.
- 50,000 RSUs were provided under Williamson’s employment agreement.
- $270K$270,000 was paid to Executive Chairman Richard Ferrari in 2024.
- $2.4M$2,427,020 was the 2022 grant-date fair value of Ferrari’s RSUs vesting over three years.
Other Tenon Medical proxy statements
- 2026 proxy statement
Steven M. Foster paid $721,334 (+96% on the year).
Filed Jun 23, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.